Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipients |
| |
Authors: | Garrigue Isabelle Doussau Adélaïde Asselineau Julien Bricout Hélène Couzi Lionel Rio Catherine Merville Pierre Fleury Hervé Lafon Marie-Edith Thiébaut Rodolphe |
| |
Affiliation: | Isabelle Garrigue, Adélaïde Doussau, Julien Asselineau, Hélène Bricout, Lionel Couzi, Catherine Rio, Pierre Merville, Hervé Fleury, Marie-Edith Lafon, and Rodolphe Thiébaut |
| |
Abstract: | In a prospective cohort of 82 renal transplant recipients, we evaluated the capacity of the cytomegalovirus (CMV) load in whole blood (WB) to predict the plasma CMV load, aiming to identify active CMV infections by using WB samples only and to deduce a WB threshold. Using quantitative real-time PCR, a total of 1,474 WB samples were assayed, of which 279 were positive for CMV, and 140 out of the 276 paired plasma samples tested positive. Thirty (36.6%) patients presented with at least one positive plasma PCR result, and 21 infection episodes (19 patients) required curative treatment (median follow-up time, 12 months). When the plasma CMV load was >500 copies/ml (n = 70), more than 94% (95% confidence interval, 86.0%, 98.4%) of WB samples had >500 copies/ml. Two prediction models were built: log10 plasma viral load (VL) was calculated as −0.3777 + 0.9342 × log10 WB VL and as −0.3777 + 0.8563 × log10 WB VL for patients with and without treatment, respectively. In the validation sample (578 routine samples), 77.2% of the observed and expected plasma viral loads were concordant (95% confidence intervals, 73.5 and 80.5%). According to the model, the plasma viral load was >500 copies/ml when the WB load was >3,170 or >4,000 copies/ml in patients with or without treatment, respectively. WB seems to be an appropriate candidate for routine CMV monitoring of transplant recipients by using a single assay. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|